Former Head of Pharmaceutical R&D of Roche Joins Pfizer
- Pfizer recently announced that it will appoint William Pao, MD, PhD, as executive vice president and chief development officer. Effective March 2022, Pao will replace Rod Mackenzie, who recently announced his intent to retire after nearly 35 years at Pfizer. Pao will report to chairman and CEO, Albert Bourla. In his role, Pao will oversee the...
